Partner Content Partner Content Bridging Collaborative Announces 2019 Keynote Speakers and C... 2019 Bridging Collaborative Keynote Speakers
News Madrigal closes on EU approval of first MASH treatment Madrigal Pharma could be just weeks away from becoming the first drugmaker to claim EU approval for a MASH treatment.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
